Capital Increase / Dilution2026-08-04

Amicogen withdraws paid-in capital increase

AMI

아미코젠

092040

+0.05

Signal Score

50CNeutral
Score50 / 100

Historical Avg Return (5d)

+0.00%

Data Coverage

100%n=2692

Risk-adjusted indicator based on 2692 historical DART filings. For informational purposes only — not investment advice.

Financial Impact

NEUTRAL

Key Numbers

  • • Initial Board Resolution Date: June 22, 2026
  • • Initial Payment Due Date: July 15, 2026
  • • Withdrawal Date: August 4, 2026

AI Analysis Summary

Amicogen, Inc. has announced the withdrawal of its previously decided third-party allocation paid-in capital increase. The decision, initially made on June 22, 2026, to raise operating funds, was canceled because the intended subscriber, YK Bionova Holdings Co., Ltd., failed to make the payment by the due date of July 15, 2026. This amendment, dated August 4, 2026, effectively nullifies the planned capital increase, resulting in no dilution for existing shareholders but also no new capital injection for the company's operations. The impact is neutral as the dilution event was canceled.

How This Event Is Evaluated

Capital Raise Evaluation

Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.

AI is used to interpret disclosures and extract structured data.

Signal scores are generated using event-specific methodologies and quantitative models.

  • Potential dilution rate
  • Issuance or conversion price
  • Funding purpose
  • Shareholder value impact
Read our full scoring methodology →

This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.

AI-processed analysis. Based on: [기재정정]주요사항보고서(유상증자결정). Source: Financial Supervisory Service (금융감독원 전자공시시스템). Raw government data is not redistributed. Not investment advice.